Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
April 13 2015 - 1:21PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number
000-23265
Salix
Pharmaceuticals, Ltd.
(Exact name of registrant as specified in its charter)
8510 Colonnade Center Drive
Raleigh, North Carolina 27615
(919) 862-1000
(Address,
including zip code, and telephone number, including area code, of registrants principal executive offices)
2.75% Convertible
Senior Notes due 2015
(Title of each class of securities covered by this Form)
None
(Titles of all
other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the
box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
Rule 12g-4(a)(1) |
|
¨ |
Rule 12g-4(a)(2) |
|
¨ |
Rule 12h-3(b)(1)(i) |
|
x |
Rule 12h-3(b)(1)(ii) |
|
¨ |
Rule 15d-6 |
|
¨ |
Approximate number of holders of record as of the certification or notice date: 29
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this certification/notice to be signed on
its behalf by the undersigned hereunto duly authorized.
Dated: April 13, 2015
|
|
|
Salix Pharmaceuticals, Ltd. |
|
|
By: |
|
/s/ Robert R. Chai-Onn |
Name: |
|
Robert R. Chai-Onn |
Title: |
|
Executive Vice President, General Counsel and Corporate Secretary |
Salix (NASDAQ:SLXP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Salix (NASDAQ:SLXP)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More Salix Pharmaceuticals Ltd News Articles